CooperCompanies Q3: Solid Performance, Innovation Ahead
Update: 2025-12-05
Description
CooperCompanies, a medical device firm, reported Q3 2025 earnings, meeting revenue expectations and surpassing profit estimates. Sales grew by 4.6% YoY to $1.07 billion, with earnings per share at $1.15, 3.2% higher than predicted. The company anticipates Q4 revenue of $1.02 billion, above forecasts. Driven by premium contact lenses and new contracts, CooperCompanies expects growth to continue with upcoming product launches. Despite Asia Pacific challenges, the company credits product availability and targeted launches for growth. Management expects market share gains, new product introductions, and improved free cash flow, but acknowledges potential headwinds from market softness and tariffs.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
